Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
This Breast Cancer Surveillance Consortium (BCSC) ADVANCE study is a large, observational pragmatic comparative effectiveness research study using high-quality, prospectively collected data from BCSC registries to generate evidence on how breast density should be integrated into decision making around breast cancer screening and preoperative diagnostic work-up. We will augment existing BCSC registry infrastructure with additional prospective data collection and collection of patient reported outcomes (PROs), CISNET modeling of long-term screening outcomes, and qualitative data from focus groups with women represented in two aims.
Full description
Aim 1: Compare the effectiveness of breast cancer screening using digital mammography alone versus digital mammography plus supplemental screening (digital breast tomosynthesis or MRI) by extent of breast density.
Sub aim 1: Evaluate whether the performance of tomosynthesis improves with years of experience, and whether any "learning curve" depends on radiologist specialty (i.e., breast imaging specialist vs. general radiologist).
Aim 2: Compare the effectiveness of preoperative MRI versus no MRI by extent of breast density among women with an initial, pathologically confirmed diagnosis of DCIS or invasive breast cancer.
Covid-19 Enhancement Aim and Hypotheses:
Develop patient-focused messaging content through focus groups that radiology facilities can use when scheduling appointments to inform women of the safety to schedule or postpone breast screening or diagnostic services.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Aim 1 Clinical Outcomes
Inclusion criteria:
Exclusion criteria:
Aim 1 Patient Reported Outcomes
Inclusion criteria:
Aim 1 Focus Groups
Inclusion criteria:
Subaim 1
Inclusion criteria:
Exclusion criteria:
Aim 2 Clinical Outcomes
Inclusion criteria:
Aim 2 Patient Reported Outcomes
Inclusion criteria:
Aim 2 Focus Groups
Inclusion criteria:
COVID-19 Enhancement Focus Groups
Inclusion criteria:
Women age 18-74 who were due for breast imaging services during the COVID pandemic and have either canceled their appointment, delayed their appointment, or kept their appointment
Women who are able to speak English and can attend calls virtually through Zoom or over the phone
In addition, for focus groups with women who have prior breast cancer:
1,341,172 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal